Literature DB >> 28411013

Physician-reported factors that encourage collaboration with community pharmacists.

Nicole C Pezzino, Macary Weck Marciniak, Megan G Smith, Stefanie P Ferreri.   

Abstract

OBJECTIVE: To determine factors that encourage physicians to establish collaborative practice agreements with community pharmacists.
METHODS: A 20-item cross-sectional survey was mailed to a random sample of 1000 family medicine physicians practicing in North Carolina. Two weeks after the initial mailing, a reminder was sent to physicians. Physicians were entered into a drawing to receive a gift card as an incentive for survey completion. The questionnaire collected demographic information, factors important to physicians for collaboration with a community pharmacist, and physician perceptions of pharmacist qualifications. Descriptive statistics were used to analyze patterns in the Likert scale survey responses.
RESULTS: Of the 1000 mailed surveys, 67 were returned as undeliverable, resulting in a final sample size of 933 surveys. One hundred forty-six family medicine physicians responded to the survey, yielding a 15.6% response rate. Respondents were 58% male, 73% had been practicing longer than 10 years, and 60% had an academic affiliation. Our results indicate that an established relationship with a community pharmacist is the most important factor when considering a collaborative practice agreement. At least 90% of physicians reported that the most important pharmacist contributions were drug therapy adverse effect management, drug interaction management, medication access assistance, prescription counseling, and medication adherence. A majority of physicians reported that community pharmacists improve quality outcomes and metrics (74% and 72%, respectively).
CONCLUSION: Physicians in North Carolina recognize the value of the services a pharmacist can provide to their patients. Developing relationships between community pharmacists and physicians and describing the value of additional credentialing in the provision of patient care will be integral in establishing collaborative practice agreements in the community setting.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28411013     DOI: 10.1016/j.japh.2017.02.016

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  4 in total

1.  Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis.

Authors:  Alexandria May; Olivia Morgan; Kristi Quairoli
Journal:  Int J MS Care       Date:  2020-02-14

2.  "Clearly they are in the circle of care, but . . .": A qualitative study exploring perceptions of personal health information sharing with community pharmacists in an integrated care model.

Authors:  Teagan Rolf von den Baumen; Jennifer Lake; Amanda C Everall; Katie Dainty; Zahava Rosenberg-Yunger; Sara J T Guilcher
Journal:  Can Pharm J (Ott)       Date:  2020-09-25

3.  Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective.

Authors:  Richard H Parrish II; Danielle Casher; Johannes van den Anker; Sandra Benavides
Journal:  Children (Basel)       Date:  2019-04-09

4.  Pharmacists-physicians collaborative intervention to reduce vaccine hesitancy and resistance: A randomized controlled trial.

Authors:  Derar H Abdel-Qader; Wail Hayajneh; Abdullah Albassam; Nathir M Obeidat; Adel M Belbeisi; Nadia Al Mazrouei; Ala'a F Al-Shaikh; Khaldoon E Nusair; Ahmad Z Al Meslamani; Asma A El-Shara; Husam El Sharu; Samah Bahy Mohammed Ebaed; Osama Mohamed Ibrahim
Journal:  Vaccine X       Date:  2021-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.